跳至主要内容
临床试验/NCT02287961
NCT02287961已完成不适用

Natural History of Anal Human Papillomavirus Infection and Associated Disease in HIV-infected Men Who Have Sex With Men: Towards an Evidence Base for the Prevention of Anal Cancer.

ANRS, Emerging Infectious Diseases1 个研究点 分布在 1 个国家目标入组 516 人开始时间: 2014年12月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
516
试验地点
1
主要终点
Evaluation of high-grade anal lesions by high resolution anoscopy

研究概览

简要总结

Multicentric epidemiological non-comparative study in France characterising evolution of anal Human papillomavirus (HPV) infection and related lesions and evaluating markers associated with the observed evolution.

Estimated enrolment: 500

Principal Outcomes

  • Detection of high-grade cytological and histological anal lesions by high resolution anoscopy
  • Spontaneous regression of high-grade anal lesions
  • Detection of anal HPV infection

Intervention (procedure):

  • Patient medical interview (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits)
  • Standard proctologic examination with digital rectal examination and 2 anal swabs (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits)
  • High resolution anoscopy (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits)

Only if lesion suggestive of Anal Intraepithelial Neoplasia (AIN) detected during High Resolution Anoscopy (HRA):

  • anal biopsy(ies) during HRA

Only if high-grade lesion:

  • HRA biannually

详细描述

Intervention (procedure):

  • Patient medical interview (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits)
  • Standard proctologic examination with digital rectal examination and 2 anal swabs (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits)
  • High resolution anoscopy (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits)

Only if lesion suggestive of Anal Intraepithelial Neoplasia (AIN) detected during High Resolution Anoscopy (HRA):

  • anal biopsy(ies) during HRA

Only if high-grade lesion (Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H), High grade Superficial Intra-epithelial Lesion (HSIL) or AIN2/3):

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
35 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Men who have sex with men
  • At least 35 years old
  • HIV-positive (documented search of HIV infection, with HIV status determined according to HAS algorithm)
  • Signed informed consent
  • Affiliated to or beneficiary of French social security
  • All severity criteria and evolution of HIV disease are accepted (including AIDS stage and co-infections)

排除标准

  • Contraindication to biopsy
  • History of anal cancer or pelvic radiotherapy
  • AIN2/3 treated during previous year
  • Current anticancer chemotherapy or within 24 months before inclusion
  • Difficulty in evaluation (anus reshaped and/or scarred)
  • Individual placed under judicial protection
  • Foreseen absence which may hamper participation; insufficient motivation; associated pathology with priority for care

结局指标

主要结局

Evaluation of high-grade anal lesions by high resolution anoscopy

时间窗: Initial inclusion visit

Quantification of spontaneous regression of high-grade anal lesions

时间窗: Month 24

Evaluation of anal HPV infection by DNA, RNA and protein detection

时间窗: Initial inclusion visit

次要结局

  • Evaluation of anal HPV infection by DNA, RNA and protein detection(Month 24)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验